Stock listing

NASDAQ:TPTX Turning Point Therapeutics Inc Stock

Follow Turning Point Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:TPTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TPTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Turning Point Therapeutics Inc on 6ix

Calls
4 calls with a replay · 4 with a transcript · latest Aug 9, 2021
Decks
8 decks · latest May 10, 2022

Events

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (May 2022)Investor deck53 slidesMay 10, 2022
Technical Presentation (April 2022)Technical15 slidesApr 13, 2022
Investor Presentation (October 2021)Investor deck46 slidesOct 8, 2021
AACR-NCI-EORTC Investor Meeting 2021Conference29 slidesOct 7, 2021
Investor Presentation (January 2021)Investor deck33 slidesJan 11, 2021
Investor Presentation (October 2020)Investor deck30 slidesOct 26, 2020
Technical Presentation (August 2020)Technical17 slidesAug 19, 2020
38th Annual J.P. Morgan Healthcare Conference (January 2020)Conference21 slidesJan 13, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carl Gordon
Other companies: ADARx Pharmaceuticals, Inc. (Co-head Global Private Equity at OrbiMed Advisors · Since at least Sep 24, 2026); Electra Therapeutics, Inc. (Director · Since at least Sep 18, 2026); BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Compass Therapeutics, Inc. (Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Jun 17, 2020); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); MBX Biosciences, Inc. (Director · Sep 12, 2024 – Feb 14, 2025 · Past); ArriVent BioPharma, Inc. (Director · Jan 25, 2024 – Jan 30, 2024 · Past); Theseus Pharmaceuticals Inc (Director · Oct 6, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Terns Pharmaceuticals, Inc. (Director · Feb 4, 2021 – Jul 15, 2024 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Adicet Bio, Inc. (Director · Sep 15, 2020 – Aug 21, 2024 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); SpringWorks Therapeutics Inc (Director · Sep 12, 2019 – Sep 12, 2019 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Alector, Inc. (Director · Feb 6, 2019 – May 10, 2019 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 18, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Feb 8, 2011 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Sep 4, 2012 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 17, 2006 – May 17, 2006 · Past)
Director · Apr 16, 2019 – Jun 15, 2020 · Past
Bihua Chen
Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Helix Acquisition Corp. III (Chairperson and CEO, Director · Since at least Jan 22, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Biomea Fusion, Inc. (Director · Since at least Apr 15, 2021); Erasca, Inc. (Director · Jul 15, 2021 – Jun 22, 2023 · Past); Monte Rosa Therapeutics, Inc. (Director · Jun 23, 2021 – Jun 23, 2021 · Past); Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 21, 2021 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Apr 27, 2021 · Past); Design Therapeutics, Inc. (Director · Mar 25, 2021 – Mar 25, 2021 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Mar 11, 2021 · Past); BioAtla, Inc. (Director · Dec 15, 2020 – Dec 18, 2020 · Past); Olema Pharmaceuticals, Inc. (Director · Nov 18, 2020 – Nov 23, 2020 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); MoonLake Immunotherapeutics (CEO and Chairman, Director · Oct 19, 2020 – Oct 22, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Jun 30, 2020 · Past); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 16, 2020 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Oct 31, 2018 · Past); Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jul 18, 2018 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past); Kiniksa Pharmaceuticals International, plc (Director · May 23, 2018 – May 29, 2018 · Past); Apellis Pharmaceuticals, Inc. (Director · Nov 8, 2017 – Nov 13, 2017 · Past); Kineta Inc. (Director · Nov 3, 2016 – Dec 14, 2017 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 1, 2016 · Past); Cellectar Biosciences, Inc. (Director · Aug 15, 2014 – Aug 15, 2014 · Past)
Director · Apr 16, 2019 – Aug 12, 2019 · Past
Patrick Machado
Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past)
Director · May 13, 2019 – Aug 17, 2022 · Past
Carol G. Gallagher
Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Tempest Therapeutics, Inc. (Director · Jun 20, 2019 – Jun 22, 2020 · Past)
Director · Jul 24, 2019 – Aug 17, 2022 · Past
Sheila Gujrathi
Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Gossamer Bio, Inc. (President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – May 10, 2018 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past)
Director · Apr 16, 2019 – Jun 15, 2020 · Past
Athena Countouriotis
Other companies: BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); Passage Bio, Inc. (Chief Executive Officer and Chairperson of the board of directors of Avenzo Therapeutics · Since at least Feb 27, 2020); Iovance Biotherapeutics, Inc. (Director · Since at least Jun 10, 2019); Cardiff Oncology, Inc. (Director · Sep 14, 2017 – Jun 20, 2019 · Past); Adverum Biotechnologies Inc (SVP, Chief Medical Officer · Jun 19, 2017 – Feb 15, 2018 · Past); Halozyme Therapeutics, Inc. (SVP and Chief Medical Officer · Jan 5, 2015 – Feb 22, 2017 · Past); Ambit Biosciences Corp (Chief Medical Officer · May 15, 2013 – Nov 10, 2014 · Past)
President & CEO, Director · Apr 16, 2019 – Aug 17, 2022 · Past
Barbara Bodem
Other companies: Option Care Health, Inc. (Director · Since at least Jan 2, 2024); BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); Enovis Corporation (Director · Since at least Apr 4, 2022); Dentsply Sirona Inc. (Interim CFO · May 6, 2022 – May 6, 2022 · Past); Syneos Health Inc (Director · Jan 15, 2022 – Sep 28, 2023 · Past); Hill-Rom Holdings Inc (SVP, Chief Financial Officer · Dec 3, 2018 – Dec 13, 2021 · Past); Invacare Corporation (Director · Aug 18, 2017 – Mar 16, 2018 · Past)
Director · Mar 31, 2021 – Aug 17, 2022 · Past
Garry A Nicholson
Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Mar 25, 2020 – Jun 22, 2023 · Past); G1 Therapeutics Inc (Director · Sep 12, 2018 – Sep 18, 2024 · Past); Five Prime Therapeutics Inc (Director · May 10, 2017 – Apr 16, 2021 · Past); Tesaro Inc (Director · May 14, 2015 – Jan 22, 2019 · Past)
Director · Jan 22, 2020 – Aug 17, 2022 · Past
Simeon George
Other companies: ADARx Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); Nkarta, Inc. (Member of Board of Directors · Since at least Jul 9, 2020); CRISPR Therapeutics AG (Director · Since at least Oct 18, 2016); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 28, 2020 · Past)
Director · Apr 16, 2019 – Aug 17, 2022 · Past
Hongbo Lu
Other companies: Zenas BioPharma, Inc. (Board Member · Since at least Sep 12, 2024); Arrowhead Pharmaceuticals, Inc. (Director · Since at least Mar 15, 2024); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 4, 2021)
Director · Apr 16, 2019 – Apr 22, 2019 · Past
All 24 people
PersonSeat
Mark J Alles
Other companies: BioMarin Pharmaceutical Inc. (Director · Jan 1, 2022 – May 23, 2023 · Past); Syros Pharmaceuticals, Inc. (Director · Dec 19, 2019 – Sep 16, 2023 · Past); Celgene Corporation (CEO, CHAIRMAN OF BOARD, Director · Feb 15, 2012 – Nov 20, 2019 · Past)
Director · May 24, 2021 – Aug 17, 2022 · Past
Jacob Chacko
Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); ORIC Pharmaceuticals, Inc. (President, Chief Executive Officer · Since at least Apr 23, 2020)
Director · Apr 16, 2019 – Jun 15, 2020 · Past
Mohammad Hirmand
Other companies: Whitehawk Therapeutics, Inc. (Director · Since at least Mar 27, 2023); Medivation Inc (Interim Chief Medical Officer · Sep 29, 2015 – Sep 28, 2016 · Past)
EVP and Chief Medical Officer · Dec 2, 2019 – Aug 17, 2022 · Past
Paolo Tombesi
Other companies: Epizyme Inc (Chief Financial Officer · Aug 19, 2019 – Feb 4, 2021 · Past); Insmed Incorporated (Chief Financial Officer · Jun 1, 2017 – Jan 3, 2019 · Past)
EVP & Chief Financial Officer · Jul 26, 2021 – Aug 17, 2022 · Past
Yi Larson
Other companies: Olema Pharmaceuticals, Inc. (Director · Since at least Apr 5, 2021); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past)
EVP & Chief Financial Officer · Aug 26, 2019 – Feb 8, 2021 · Past
Andrew John Partridge
Other companies: GRAIL, Inc. (Chief Growth Officer · Since at least Jun 1, 2026)
EVP & Chief Commercial Officer · Jul 13, 2020 – Feb 9, 2022 · Past
Jingrong Jean Cui
Other companies: BlossomHill Therapeutics, Inc. (President and CEO, Director · Since at least Aug 6, 2026)
Director · Apr 16, 2019 – Jun 9, 2020 · Past
Kyri Van Hoose
Other companies: Dermata Therapeutics, Inc. (Senior Vice President, Chief Financial Officer · Since at least Sep 1, 2021)
Principal Accounting Officer · May 14, 2021 – May 14, 2021 · Past
Siegfried Reich
Other companies: SGX Pharmaceuticals Inc (VP, Drug Discovery · Feb 1, 2006 – Aug 20, 2008 · Past)
EVP & Chief Scientific Officer · Mar 2, 2020 – Feb 9, 2022 · Past
Steve M Sabus
Other companies: Syndax Pharmaceuticals, Inc. (Chief Commercial Officer · Dec 5, 2022 – Dec 5, 2022 · Past)
SVP & Chief Commercial Officer · May 31, 2022 – Aug 17, 2022 · Past
Yishan Li
Other companies: BlossomHill Therapeutics, Inc. (Executive Chairman, Director · Since at least Aug 6, 2026)
Director · Apr 16, 2019 – Apr 16, 2019 · Past
Annette NorthEVP & General Counsel · Apr 16, 2019 – Feb 9, 2022 · Past
Brian Lee BakerSVP of Finance and Admin. · Apr 16, 2019 – Mar 22, 2021 · Past
Brian SunSVP & General Counsel · Apr 11, 2022 – Aug 17, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Turning Point Therapeutics Inc.